Treatment of psoriasis with ginger

Phase 3

• Conditions: Psoriasis.; Psoriasis vulgaris; L40.0

• Registration Number: IRCT20190128042532N1
• Lead Sponsor: Islamic Azad University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 42

Inclusion Criteria

Patient's consent to participate in the study
Candidate of phototherapy at Razi Hospital
Generalized plaque type psoriasis
Patients who have not taken a systemic, topical drug in the last 3 months
Age 18-75 years
Both sexes

Exclusion Criteria

Pregnancy
Breastfeeding
A history of allergy to ginger
Photosensitive diseases like lupus and porphyria
Alcohol and Tobacco
Systemic and topical administration of anti-psoriasis drugs
Liver and kidney disease, diabetes, hypertension and coagulation disorders

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
PASI score. Timepoint: Baseline ? 6 and 12 weeks. Method of measurement: PASI index measuring device.

Secondary Outcome Measures

Name	Time	Method
DLQI. Timepoint: Baseline? 6 and 12 weeks. Method of measurement: questionnaire.